🚀 VC round data is live in beta, check it out!
Medicalgorithmics Valuation Multiples
Discover revenue and EBITDA valuation multiples for Medicalgorithmics and similar public comparables like Meditera, Nexstim, BioStem Technologies, Outset Medical and more.
Medicalgorithmics Overview
About Medicalgorithmics
Medicalgorithmics SA is a medical technology company. It is engaged in the development of Digital Signal Processing (DSP) algorithms development and software and hardware electronics design for medical applications. The company specializes in providing advance technological solutions in the field of cardiac diagnostics, with a particular focus on ECG signal analysis. The group concentrates on the production and development of its flagship product Pocket ECG - a system for remote monitoring of cardiac arrhythmias. The offered solutions include algorithms and diagnostic systems used in remote heart monitoring. The company operates in Poland, the USA, and other, with majority of revenue from the USA.
Founded
2005
HQ
Employees
214
Website
Sectors
Financials (LTM)
EV
$84M
Medicalgorithmics Financials
Medicalgorithmics reported last 12-month revenue of $10M and negative EBITDA of ($215K).
In the same LTM period, Medicalgorithmics generated $4M in gross profit, ($215K) in EBITDA losses, and had net loss of ($2M).
Revenue (LTM)
Medicalgorithmics P&L
In the most recent fiscal year, Medicalgorithmics reported revenue of $7M and EBITDA of ($3M).
Medicalgorithmics expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $10M | XXX | $7M | XXX | XXX | XXX |
| Gross Profit | $4M | XXX | $6M | XXX | XXX | XXX |
| Gross Margin | 37% | XXX | 85% | XXX | XXX | XXX |
| EBITDA | ($215K) | XXX | ($3M) | XXX | XXX | XXX |
| EBITDA Margin | (2%) | XXX | (49%) | XXX | XXX | XXX |
| EBIT Margin | (16%) | XXX | (64%) | XXX | XXX | XXX |
| Net Profit | ($2M) | XXX | ($4M) | XXX | XXX | XXX |
| Net Margin | (19%) | XXX | (62%) | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Medicalgorithmics Stock Performance
Medicalgorithmics has current market cap of $80M, and enterprise value of $84M.
Market Cap Evolution
Medicalgorithmics' stock price is $8.08.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $84M | $80M | 0.1% | XXX | XXX | XXX | $-0.42 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialMedicalgorithmics Valuation Multiples
Medicalgorithmics trades at 8.0x EV/Revenue multiple, and (390.8x) EV/EBITDA.
EV / Revenue (LTM)
Medicalgorithmics Financial Valuation Multiples
As of April 20, 2026, Medicalgorithmics has market cap of $80M and EV of $84M.
Equity research analysts estimate Medicalgorithmics' 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Medicalgorithmics has a P/E ratio of (40.4x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $80M | XXX | $80M | XXX | XXX | XXX |
| EV (current) | $84M | XXX | $84M | XXX | XXX | XXX |
| EV/Revenue | 8.0x | XXX | 12.6x | XXX | XXX | XXX |
| EV/EBITDA | (390.8x) | XXX | (25.5x) | XXX | XXX | XXX |
| EV/EBIT | (49.9x) | XXX | (19.6x) | XXX | XXX | XXX |
| EV/Gross Profit | 21.6x | XXX | 14.8x | XXX | XXX | XXX |
| P/E | (40.4x) | XXX | (19.3x) | XXX | XXX | XXX |
| EV/FCF | (18.1x) | XXX | (13.1x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Medicalgorithmics Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Medicalgorithmics Margins & Growth Rates
Medicalgorithmics' revenue in the last 12 month grew by 57%.
Medicalgorithmics' revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.0M for the same period.
Medicalgorithmics' rule of 40 is 85% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Medicalgorithmics' rule of X is 186% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Medicalgorithmics Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 57% | XXX | 30% | XXX | XXX | XXX |
| EBITDA Margin | (2%) | XXX | (49%) | XXX | XXX | XXX |
| EBITDA Growth | (1490%) | XXX | (56%) | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 85% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 186% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 18% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 153% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Medicalgorithmics Public Comps
See public comps and valuation multiples for other Medical Devices comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Medicalgorithmics | XXX | XXX | XXX | XXX | XXX | XXX |
| Meditera | XXX | XXX | XXX | XXX | XXX | XXX |
| Nexstim | XXX | XXX | XXX | XXX | XXX | XXX |
| BioStem Technologies | XXX | XXX | XXX | XXX | XXX | XXX |
| Outset Medical | XXX | XXX | XXX | XXX | XXX | XXX |
| Optiscan Imaging | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Medicalgorithmics M&A Activity
Medicalgorithmics acquired XXX companies to date.
Last acquisition by Medicalgorithmics was on XXXXXXXX, XXXXX. Medicalgorithmics acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Medicalgorithmics
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialMedicalgorithmics Investment Activity
Medicalgorithmics invested in XXX companies to date.
Medicalgorithmics made its latest investment on XXXXXXXX, XXXXX. Medicalgorithmics invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Medicalgorithmics
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Medicalgorithmics
| When was Medicalgorithmics founded? | Medicalgorithmics was founded in 2005. |
| Where is Medicalgorithmics headquartered? | Medicalgorithmics is headquartered in Poland. |
| How many employees does Medicalgorithmics have? | As of today, Medicalgorithmics has over 214 employees. |
| Is Medicalgorithmics publicly listed? | Yes, Medicalgorithmics is a public company listed on Warsaw Stock Exchange. |
| What is the stock symbol of Medicalgorithmics? | Medicalgorithmics trades under MDG ticker. |
| When did Medicalgorithmics go public? | Medicalgorithmics went public in 2011. |
| Who are competitors of Medicalgorithmics? | Medicalgorithmics main competitors are Meditera, Nexstim, BioStem Technologies, Outset Medical. |
| What is the current market cap of Medicalgorithmics? | Medicalgorithmics' current market cap is $80M. |
| What is the current revenue of Medicalgorithmics? | Medicalgorithmics' last 12 months revenue is $10M. |
| What is the current revenue growth of Medicalgorithmics? | Medicalgorithmics revenue growth (NTM/LTM) is 57%. |
| What is the current EV/Revenue multiple of Medicalgorithmics? | Current revenue multiple of Medicalgorithmics is 8.0x. |
| Is Medicalgorithmics profitable? | No, Medicalgorithmics is not profitable. |
| What is the current EBITDA of Medicalgorithmics? | Medicalgorithmics has negative EBITDA and is not profitable. |
| What is Medicalgorithmics' EBITDA margin? | Medicalgorithmics' last 12 months EBITDA margin is (2%). |
| What is the current EV/EBITDA multiple of Medicalgorithmics? | Current EBITDA multiple of Medicalgorithmics is (390.8x). |
| What is the current FCF of Medicalgorithmics? | Medicalgorithmics' last 12 months FCF is ($5M). |
| What is Medicalgorithmics' FCF margin? | Medicalgorithmics' last 12 months FCF margin is (44%). |
| What is the current EV/FCF multiple of Medicalgorithmics? | Current FCF multiple of Medicalgorithmics is (18.1x). |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.